Quarterly report pursuant to Section 13 or 15(d)

Earnings Per Share ("EPS") (Details 2)

v3.22.1
Earnings Per Share ("EPS") (Details 2) - shares
shares in Thousands
 3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Conversion of common units    
Antidilutive securities    
Weighted average antidilutive securities excluded from computation of diluted earnings per share (in shares) 1,384 1,246
Conversion of redeemable noncontrolling interests    
Antidilutive securities    
Weighted average antidilutive securities excluded from computation of diluted earnings per share (in shares) 806 940
Weighted average restricted shares and deferred shares    
Antidilutive securities    
Weighted average antidilutive securities excluded from computation of diluted earnings per share (in shares) 399 419
Weighted average unvested TB-PIUs    
Antidilutive securities    
Weighted average antidilutive securities excluded from computation of diluted earnings per share (in shares) 172 131
Weighted average unvested PB-PIUs    
Antidilutive securities    
Weighted average antidilutive securities excluded from computation of diluted earnings per share (in shares)   228